BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 17082584)

  • 1. CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+CD5+ B cells.
    Chunsong H; Yuling H; Li W; Jie X; Gang Z; Qiuping Z; Qingping G; Kejian Z; Li Q; Chang AE; Youxin J; Jinquan T
    J Immunol; 2006 Nov; 177(10):6713-22. PubMed ID: 17082584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia.
    Hu C; Xiong J; Zhang L; Huang B; Zhang Q; Li Q; Yang M; Wu Y; Wu Q; Shen Q; Gao Q; Zhang K; Sun Z; Liu J; Jin Y; Tan J
    Cell Mol Immunol; 2004 Aug; 1(4):280-94. PubMed ID: 16225771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL19 and CXCL13 synergistically regulate interaction between B cell acute lymphocytic leukemia CD23+CD5+ B Cells and CD8+ T cells.
    Wang X; Yuling H; Yanping J; Xinti T; Yaofang Y; Feng Y; Ruijin X; Li W; Lang C; Jingyi L; Zhiqing T; Jingping O; Bing X; Li Q; Chang AE; Sun Z; Youxin J; Jinquan T
    J Immunol; 2007 Sep; 179(5):2880-8. PubMed ID: 17709502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8(+)CD34(+) T cells from patients with T-cell-lineage acute lymphocytic leukemia.
    Qiuping Z; Jie X; Youxin J; Qun W; Wei J; Chun L; Jin W; Yan L; Chunsong H; Mingzhen Y; Qingping G; Qun L; Kejian Z; Zhimin S; Junyan L; Jinquan T
    Oncogene; 2005 Jan; 24(4):573-84. PubMed ID: 15580304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function.
    Schaerli P; Willimann K; Lang AB; Lipp M; Loetscher P; Moser B
    J Exp Med; 2000 Dec; 192(11):1553-62. PubMed ID: 11104798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.
    Bürkle A; Niedermeier M; Schmitt-Gräff A; Wierda WG; Keating MJ; Burger JA
    Blood; 2007 Nov; 110(9):3316-25. PubMed ID: 17652619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental stage-specific shift in responsiveness to chemokines during human B-cell development.
    Honczarenko M; Glodek AM; Swierkowski M; Na IK; Silberstein LE
    Exp Hematol; 2006 Aug; 34(8):1093-100. PubMed ID: 16863916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases.
    Armengol MP; Cardoso-Schmidt CB; Fernández M; Ferrer X; Pujol-Borrell R; Juan M
    J Immunol; 2003 Jun; 170(12):6320-8. PubMed ID: 12794165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.
    López-Giral S; Quintana NE; Cabrerizo M; Alfonso-Pérez M; Sala-Valdés M; De Soria VG; Fernández-Rañada JM; Fernández-Ruiz E; Muñoz C
    J Leukoc Biol; 2004 Aug; 76(2):462-71. PubMed ID: 15155773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL19 and CXCL12 trigger in vitro chemotaxis of human mantle cell lymphoma B cells.
    Corcione A; Arduino N; Ferretti E; Raffaghello L; Roncella S; Rossi D; Fedeli F; Ottonello L; Trentin L; Dallegri F; Semenzato G; Pistoia V
    Clin Cancer Res; 2004 Feb; 10(3):964-71. PubMed ID: 14871974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases.
    Aust G; Sittig D; Becherer L; Anderegg U; Schütz A; Lamesch P; Schmücking E
    Eur J Endocrinol; 2004 Feb; 150(2):225-34. PubMed ID: 14763921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia.
    Alfonso-Pérez M; López-Giral S; Quintana NE; Loscertales J; Martín-Jiménez P; Muñoz C
    J Leukoc Biol; 2006 Jun; 79(6):1157-65. PubMed ID: 16603585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling through TNF receptor p55 in TNF-alpha-deficient mice alters the CXCL13/CCL19/CCL21 ratio in the spleen and induces maturation and migration of anergic B cells into the B cell follicle.
    Mandik-Nayak L; Huang G; Sheehan KC; Erikson J; Chaplin DD
    J Immunol; 2001 Aug; 167(4):1920-8. PubMed ID: 11489971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
    Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
    Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets.
    Johnston B; Kim CH; Soler D; Emoto M; Butcher EC
    J Immunol; 2003 Sep; 171(6):2960-9. PubMed ID: 12960320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia.
    Catusse J; Leick M; Groch M; Clark DJ; Buchner MV; Zirlik K; Burger M
    Mol Cancer; 2010 Nov; 9():297. PubMed ID: 21092185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes.
    Till KJ; Lin K; Zuzel M; Cawley JC
    Blood; 2002 Apr; 99(8):2977-84. PubMed ID: 11929789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.
    Luther SA; Bidgol A; Hargreaves DC; Schmidt A; Xu Y; Paniyadi J; Matloubian M; Cyster JG
    J Immunol; 2002 Jul; 169(1):424-33. PubMed ID: 12077273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A coordinated change in chemokine responsiveness guides plasma cell movements.
    Hargreaves DC; Hyman PL; Lu TT; Ngo VN; Bidgol A; Suzuki G; Zou YR; Littman DR; Cyster JG
    J Exp Med; 2001 Jul; 194(1):45-56. PubMed ID: 11435471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells.
    Kim CH; Rott LS; Clark-Lewis I; Campbell DJ; Wu L; Butcher EC
    J Exp Med; 2001 Jun; 193(12):1373-81. PubMed ID: 11413192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.